Archived 48: Summary of NACI statement of December 9, 2022: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2022) on “Archived 48: Summary of NACI statement of December 9, 2022: Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration”. What you need to know: The use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.